Clinical Trial Results:
A Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of SAR443820 in adult participants with
amyotrophic lateral sclerosis, followed by an open-label extension
Summary
|
|
EudraCT number |
2021-004156-42 |
Trial protocol |
SE DE IT NL BE ES FR PL |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Feb 2025
|
First version publication date |
13 Feb 2025
|
Other versions |
|
Summary report(s) |
2021-004156-42 (ACT16970) _Summary Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.